Sales & Marketing The drug pricing discussion that won’t disappear Discussions of the pharma industry in the political sphere have lingered on pricing for a number of years.
News Sanders calls on FDA to allow low-cost rivals to $375k Catal... US Senator Bernie Sanders says the FDA should allow pharmacies and generic manufacturers to make low-cost copies of Catalyst Pharma’s rare disease drug Firdapse, which is at the heart of a
News Marathon halts launch of Duchenne drug after price outcry Company says it will listen to concerns of patient advocates
Oncology LSX2026: Addressing adult eye cancer, with Roi Raz Roi Raz, CEO of ReBio Pharma, discusses injectable, bioresorbable sustained release delivery for ophthalmic therapeutics at LSX 2026.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
